{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T21:32:32Z","timestamp":1771191152822,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10875-020-00811-9","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T02:02:28Z","timestamp":1593482548000},"page":"861-871","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Treosulfan-Based Conditioning Regimen in Haematopoietic Stem Cell Transplantation with TCR\u03b1\u03b2\/CD19 Depletion in Nijmegen Breakage Syndrome."],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2354-2588","authenticated-orcid":false,"given":"Alexandra","family":"Laberko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0319-3699","authenticated-orcid":false,"given":"Elvira","family":"Sultanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3800-8927","authenticated-orcid":false,"given":"Elena","family":"Gutovskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7696-1153","authenticated-orcid":false,"given":"Svetlana","family":"Radygina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9083-4783","authenticated-orcid":false,"given":"Elena","family":"Deripapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5962-1264","authenticated-orcid":false,"given":"Aishat","family":"Kantulaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0231-1617","authenticated-orcid":false,"given":"Pavel","family":"Trakhtman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0079-7761","authenticated-orcid":false,"given":"Varvara","family":"Brilliantova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1804-9761","authenticated-orcid":false,"given":"Julia","family":"Starichkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3113-4939","authenticated-orcid":false,"given":"Anna","family":"Shcherbina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1735-0093","authenticated-orcid":false,"given":"Michael","family":"Maschan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0016-6698","authenticated-orcid":false,"given":"Alexei","family":"Maschan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2689-0569","authenticated-orcid":false,"given":"Dmitry","family":"Balashov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,30]]},"reference":[{"issue":"1","key":"811_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1172-7-13","volume":"7","author":"KH Chrzanowska","year":"2012","unstructured":"Chrzanowska KH, Gregorek H, Dembowska-Bagi\u0144ska B, Kalina MA, Digweed M. Nijmegen breakage syndrome (NBS). Orphanet J Rare Dis. 2012;7(1):13.","journal-title":"Orphanet J Rare Dis"},{"key":"811_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fped.2019.00295","volume":"7","author":"R Castagnoli","year":"2019","unstructured":"Castagnoli R, Delmonte OM, Calzoni E, Notarangelo LD. Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives. Front Pediatr. 2019;7:295.","journal-title":"Front Pediatr"},{"issue":"1","key":"811_CR3","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jaci.2017.02.036","volume":"141","author":"J Slack","year":"2018","unstructured":"Slack J, Albert MH, Balashov D, Belohradsky BH, Bertaina A, Bleesing J, et al. Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders. Journal of Allergy and Clinical Immunology. 2018;141(1):322\u2013328.e10.","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"811_CR4","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/bmt.2009.207","volume":"45","author":"MH Albert","year":"2010","unstructured":"Albert MH, Gennery AR, Greil J, Cale CM, Kalwak K, Kondratenko I, et al. Successful SCT for Nijmegen breakage syndrome. Bone Marrow Transplant. 2010;45(4):622\u20136.","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"811_CR5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s10875-015-0186-9","volume":"35","author":"B Wolska-Ku\u015bnierz","year":"2015","unstructured":"Wolska-Ku\u015bnierz B, Gregorek H, Chrzanowska K, Pi\u0105tosa B, Pietrucha B, on behalf of the Inborn Errors Working Party of the Society for European Blood and Marrow Transplantation and the European Society for Immune Deficiencies, et al. Nijmegen breakage syndrome: clinical and immunological features, long-term outcome and treatment options \u2013 a retrospective analysis. J Clin Immunol. 2015 Aug;35(6):538\u201349.","journal-title":"J Clin Immunol"},{"key":"811_CR6","doi-asserted-by":"publisher","unstructured":"Deripapa E, Balashov D, Rodina Y, Laberko A, Myakova N, Davydova NV, et al. Prospective study of a cohort of Russian Nijmegen breakage syndrome patients demonstrating predictive value of low kappa-deleting recombination excision circle (KREC) numbers and beneficial effect of hematopoietic stem cell transplantation (HSCT). Frontiers in Immunology [Internet]. 2017 [cited 2017 Sep 24];8. Available from: https:\/\/doi.org\/10.3389\/fimmu.2017.00807.","DOI":"10.3389\/fimmu.2017.00807"},{"issue":"26","key":"811_CR7","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1182\/blood-2013-01-479733","volume":"122","author":"R Peffault de Latour","year":"2013","unstructured":"Peffault de Latour R, Porcher R, Dalle J-H, Aljurf M, Korthof ET, Svahn J, et al. Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. Blood. 2013;122(26):4279\u201386.","journal-title":"Blood."},{"issue":"3","key":"811_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.bbmt.2017.11.009","volume":"24","author":"MA Slatter","year":"2018","unstructured":"Slatter MA, Rao K, Abd Hamid IJ, Nademi Z, Chiesa R, Elfeky R, et al. Treosulfan and fludarabine conditioning for hematopoietic stem cell transplantation in children with primary immunodeficiency: UK experience. Biology of Blood and Marrow Transplantation. 2018;24(3):529\u201336.","journal-title":"Biology of Blood and Marrow Transplantation."},{"issue":"4","key":"811_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/sj.bmt.1705259","volume":"37","author":"N Kr\u00f6ger","year":"2006","unstructured":"Kr\u00f6ger N, Shimoni A, Zabelina T, Schieder H, Panse J, Ayuk F, et al. Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS). Bone Marrow Transplant. 2006 Feb;37(4):339\u201344.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"811_CR10","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1182\/blood-2002-11-3615","volume":"103","author":"J Casper","year":"2004","unstructured":"Casper J, Knauf W, Kiefer T, Wolff D, Steiner B, Hammer U, et al. Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation. Blood. 2004 Jan 15;103(2):725\u201331.","journal-title":"Blood."},{"issue":"1","key":"811_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/17474086.2016.1268048","volume":"10","author":"CL Ebens","year":"2017","unstructured":"Ebens CL, MacMillan ML, Wagner JE. Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations. Expert Rev Hematol. 2017;10(1):81\u201397.","journal-title":"Expert Rev Hematol"},{"key":"811_CR12","unstructured":"Shah RM, Elfeky R, Nademi Z, Qasim W, Amrolia P, Chiesa R, et al. T-cell receptor \u03b1\u03b2 + and CD19 + cell\u2013depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency. Journal of Allergy and Clinical Immunology [Internet]. 2017 Aug [cited 2017 Dec 17]; Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674917312022"},{"key":"811_CR13","doi-asserted-by":"crossref","unstructured":"Laberko A, Sultanova E, Gutovskaya E, Shipitsina I, Shelikhova L, Kurnikova E, et al. Mismatched related versus matched unrelated donors in TCR\u03b1\u03b2\/CD19-depleted HSCT for primary immunodeficiencies. Blood. 2019;blood.2019001757.","DOI":"10.1182\/blood.2019001757"},{"issue":"11","key":"811_CR14","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/j.bbmt.2015.07.008","volume":"21","author":"D Balashov","year":"2015","unstructured":"Balashov D, Shcherbina A, Maschan M, Trakhtman P, Skvortsova Y, Shelikhova L, et al. Single-center experience of unrelated and haploidentical stem cell transplantation with TCR\u03b1\u03b2 and CD19 depletion in children with primary immunodeficiency syndromes. Biology of Blood and Marrow Transplantation. 2015;21(11):1955\u201362.","journal-title":"Biology of Blood and Marrow Transplantation."},{"issue":"9","key":"811_CR15","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.bbmt.2011.01.001","volume":"17","author":"P Stepensky","year":"2011","unstructured":"Stepensky P, Shapira MY, Balashov D, Trakhtman P, Skorobogatova E, Rheingold L, et al. Bone marrow transplantation for Fanconi Anemia using fludarabine-based conditioning. Biology of Blood and Marrow Transplantation. 2011;17(9):1282\u20138.","journal-title":"Biology of Blood and Marrow Transplantation."},{"key":"811_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3389\/fped.2019.00557","volume":"7","author":"B Wolska-Ku\u015bnierz","year":"2020","unstructured":"Wolska-Ku\u015bnierz B, Gennery AR. Hematopoietic stem cell transplantation for DNA double strand breakage repair disorders. Front Pediatr. 2020 Jan 15;7:557.","journal-title":"Front Pediatr"},{"issue":"03","key":"811_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-0035-1548841","volume":"227","author":"M Chao","year":"2015","unstructured":"Chao M, Ebell W, Bader P, Beier R, Burkhardt B, Feuchtinger T, et al. Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi Anemia. Klin Padiatr. 2015 May 18;227(03):157\u201365.","journal-title":"Klin Padiatr"},{"issue":"10","key":"811_CR18","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s40262-018-0647-4","volume":"57","author":"M Roma\u0144ski","year":"2018","unstructured":"Roma\u0144ski M, Wachowiak J, G\u0142\u00f3wka FK. Treosulfan pharmacokinetics and its variability in pediatric and adult patients undergoing conditioning prior to hematopoietic stem cell transplantation: current state of the art, in-depth analysis, and perspectives. Clin Pharmacokinet. 2018 Oct;57(10):1255\u201365.","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"811_CR19","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jaci.2013.01.047","volume":"131","author":"E Haddad","year":"2013","unstructured":"Haddad E, Leroy S, Buckley RH. B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment? J Allergy Clin Immunol. 2013 Apr;131(4):994\u20131000.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"811_CR20","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.jaci.2016.01.053","volume":"138","author":"K Rao","year":"2016","unstructured":"Rao K, Adams S, Qasim W, Allwood Z, Worth A, Silva J, et al. Effect of stem cell source on long-term chimerism and event-free survival in children with primary immunodeficiency disorders after fludarabine and melphalan conditioning regimen. J Allergy Clin Immunol. 2016 Oct;138(4):1152\u201360.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"811_CR21","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1182\/blood-2006-07-029090","volume":"109","author":"M Cavazzana-Calvo","year":"2007","unstructured":"Cavazzana-Calvo M, Carlier F, Le Deist F, Morillon E, Taupin P, Gautier D, et al. Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype. Blood. 2007 May 15;109(10):4575\u201381.","journal-title":"Blood."},{"issue":"4","key":"811_CR22","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.jaci.2007.08.007","volume":"120","author":"E Mazzolari","year":"2007","unstructured":"Mazzolari E, Forino C, Guerci S, Imberti L, Lanfranchi A, Porta F, et al. Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency. J Allergy Clin Immunol. 2007 Oct;120(4):892\u20139.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"811_CR23","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/bjh.14960","volume":"179","author":"MYEC van der Stoep","year":"2017","unstructured":"van der Stoep MYEC, Bertaina A, ten Brink MH, Bredius RG, Smiers FJ, Wanders DCM, et al. High interpatient variability of treosulfan exposure is associated with early toxicity in paediatric HSCT: a prospective multicentre study. Br J Haematol. 2017 Dec;179(5):772\u201380.","journal-title":"Br J Haematol"},{"key":"811_CR24","doi-asserted-by":"crossref","unstructured":"on behalf of the EBMT Inborn Errors and Paediatric Diseases Working Parties, Slatter MA, Boztug H, P\u00f6tschger U, Sykora K-W, Lankester A, et al. Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases. Bone Marrow Transplant. 2015 Dec;50(12):1536\u201341.","DOI":"10.1038\/bmt.2015.171"},{"issue":"3","key":"811_CR25","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1182\/blood-2016-03-704015","volume":"128","author":"B Morillo-Gutierrez","year":"2016","unstructured":"Morillo-Gutierrez B, Beier R, Rao K, Burroughs L, Schulz A, Ewins A-M, et al. Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience. Blood. 2016 Jul 21;128(3):440\u20138.","journal-title":"Blood."},{"issue":"9915","key":"811_CR26","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","volume":"383","author":"T G\u00fcng\u00f6r","year":"2014","unstructured":"G\u00fcng\u00f6r T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D, et al. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet. 2014 Feb;383(9915):436\u201348.","journal-title":"Lancet"},{"issue":"16","key":"811_CR27","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1182\/blood-2016-09-743112","volume":"129","author":"PA Mehta","year":"2017","unstructured":"Mehta PA, Davies SM, Leemhuis T, Myers K, Kernan NA, Prockop SE, et al. Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study. Blood. 2017 Apr 20;129(16):2308\u201315.","journal-title":"Blood."},{"issue":"1","key":"811_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bbmt.2007.09.015","volume":"14","author":"IH Bartelink","year":"2008","unstructured":"Bartelink IH, Bredius RGM, Ververs TT, Raphael MF, van Kesteren C, Bierings M, et al. Once-daily intravenous busulfan with therapeutic drug monitoring compared to conventional oral busulfan improves survival and engraftment in children undergoing allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation. 2008 Jan;14(1):88\u201398.","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"2","key":"811_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1182\/blood-2013-01-476432","volume":"123","author":"C Schuetz","year":"2014","unstructured":"Schuetz C, Neven B, Dvorak CC, Leroy S, Ege MJ, Pannicke U, et al. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID. Blood. 2014 Jan 9;123(2):281\u20139.","journal-title":"Blood."},{"key":"811_CR30","first-page":"434","volume":"7","author":"P Shaw","year":"2019","unstructured":"Shaw P, Shizuru J, Hoenig M, Veys P. IEWP-EBMT. Conditioning Perspectives for Primary Immunodeficiency Stem Cell Transplants Front Pediatr. 2019 Nov 6;7:434.","journal-title":"Conditioning Perspectives for Primary Immunodeficiency Stem Cell Transplants Front Pediatr"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00811-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-020-00811-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00811-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T23:38:06Z","timestamp":1625009886000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-020-00811-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,30]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["811"],"URL":"https:\/\/doi.org\/10.1007\/s10875-020-00811-9","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,30]]},"assertion":[{"value":"24 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"MM: lecturer\u2019s fee from <i>Miltenyi Biotec.<\/i> The remaining authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}